1887

Abstract

Foot-and-mouth disease virus (FMDV) outer capsid proteins 1B, 1C and 1D contribute to the virus serotype distribution and antigenic variants that exist within each of the seven serotypes. This study presents phylogenetic, genetic and antigenic analyses of South African Territories (SAT) serotypes prevalent in sub-Saharan Africa. Here, we show that the high levels of genetic diversity in the P1-coding region within the SAT serotypes are reflected in the antigenic properties of these viruses and therefore have implications for the selection of vaccine strains that would provide the best vaccine match against emerging viruses. Interestingly, although SAT1 and SAT2 viruses displayed similar genetic variation within each serotype (32 % variable amino acids), antigenic disparity, as measured by r-values, was less pronounced for SAT1 viruses compared with SAT2 viruses within our dataset, emphasizing the high antigenic variation within the SAT2 serotype. Furthermore, we combined amino acid variation and the r-values with crystallographic structural data and were able to predict areas on the surface of the FMD virion as antigenically relevant. These sites were mostly consistent with antigenic sites previously determined for types A, O and C using mAbs and escape mutant studies. Our methodology offers a quick alternative to determine antigenic relevant sites for FMDV field strains.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.032839-0
2011-10-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/10/2297.html?itemId=/content/journal/jgv/10.1099/vir.0.032839-0&mimeType=html&fmt=ahah

References

  1. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., Brown F. 1989; The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337:709–716 [View Article][PubMed]
    [Google Scholar]
  2. Ansell D. M., Samuel A. R., Carpenter W. C., Knowles N. J. 1994; Genetic relationships between foot-and-mouth disease type Asia 1 viruses. Epidemiol Infect 112:213–224 [View Article][PubMed]
    [Google Scholar]
  3. Bastos A. D. S. 1998; Detection and characterization of foot-and-mouth disease virus in sub-Saharan Africa. Onderstepoort J Vet Res 65:37–47[PubMed]
    [Google Scholar]
  4. Bastos A. D. S., Boshoff C. I., Keet D. F., Bengis R. G., Thomson G. R. 2000; Natural transmission of foot-and-mouth disease virus between African buffalo (Syncerus caffer) and impala (Aepyceros melampus) in the Kruger National Park, South Africa. Epidemiol Infect 124:591–598 [View Article][PubMed]
    [Google Scholar]
  5. Bastos A. D. S., Haydon D. T., Forsberg R., Knowles N. J., Anderson E. C., Bengis R. G., Nel L. H., Thomson G. R. 2001; Genetic heterogeneity of SAT-1 type foot-and-mouth disease viruses in southern Africa. Arch Virol 146:1537–1551 [View Article][PubMed]
    [Google Scholar]
  6. Bastos A. D. S., Anderson E. C., Bengis R. G., Keet D. F., Winterbach H. K., Thomson G. R. 2003a; Molecular epidemiology of SAT3-type foot-and-mouth disease. Virus Genes 27:283–290 [View Article][PubMed]
    [Google Scholar]
  7. Bastos A. D. S., Haydon D. T., Sangaré O., Boshoff C. I., Edrich J. L., Thomson G. R. 2003b; The implications of virus diversity within the SAT 2 serotype for control of foot-and-mouth disease in sub-Saharan Africa. J Gen Virol 84:1595–1606 [View Article][PubMed]
    [Google Scholar]
  8. Baxt B., Vakharia V., Moore D. M., Franke A. J., Morgan D. O. 1989; Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. J Virol 63:2143–2151[PubMed]
    [Google Scholar]
  9. Bolwell C., Clarke B. E., Parry N. R., Ouldridge E. J., Brown F., Rowlands D. J. 1989; Epitope mapping of foot-and-mouth disease virus with neutralising monoclonal antibodies. J Gen Virol 70:59–68 [View Article]
    [Google Scholar]
  10. Brehm K. E., Kumar N., Thulke H. H., Haas B. 2008; High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine 26:1681–1687 [View Article][PubMed]
    [Google Scholar]
  11. Bronsvoort B. M., Radford A. D., Tanya V. N., Nfon C., Kitching R. P., Morgan K. L. 2004; Molecular epidemiology of foot-and-mouth disease viruses in the Adamawa province of Cameroon. J Clin Microbiol 42:2186–2196 [View Article][PubMed]
    [Google Scholar]
  12. Condy J. B., Hedger R. S., Hamblin C., Barnett I. T. R. 1985; The duration of the foot-and-mouth disease virus carrier state in African buffalo (i) in the individual animal and (ii) in a free-living herd. Comp Immunol Microbiol Infect Dis 8:259–265 [View Article][PubMed]
    [Google Scholar]
  13. Crowther J. R., Farias S., Carpenter W. C., Samuel A. R. 1993a; Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol 74:1547–1553 [View Article][PubMed]
    [Google Scholar]
  14. Crowther J. R., Rowe C. A., Butcher R. 1993b; Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus. Epidemiol Infect 111:391–406 [View Article][PubMed]
    [Google Scholar]
  15. Dawe P. S., Flanagan F. O., Madekurozwa R. L., Sorensen K. J., Anderson E. C., Foggin C. M., Ferris N. P., Knowles N. J. 1994; Natural transmission of foot-and-mouth disease virus from African buffalo (Syncerus caffer) to cattle in a wildlife area of Zimbabwe. Vet Rec 134:230–232 [View Article][PubMed]
    [Google Scholar]
  16. Esterhuysen J. J. 1994; The antigenic variation of foot-and-mouth disease viruses and its significance in the epidemiology of the disease in southern Africa . MSc dissertation, University of Pretoria, South Africa
    [Google Scholar]
  17. Ferris N. P., Donaldson A. I. 1992; The World Reference Laboratory for Foot-and-Mouth Disease: a review of thirty-three years of activity (1958–1991). Rev Sci Tech 11:657–684[PubMed]
    [Google Scholar]
  18. FMD Reference Laboratory Network 2010 Annual OIE/FAO FMD Reference Laboratory Network Report. WRLFMD Pirbright, UK: IAH;
    [Google Scholar]
  19. Guzman E., Taylor G., Charleston B., Ellis S. A. 2010; Induction of a cross-reactive CD8+ T cell response following foot-and-mouth disease virus vaccination. J Virol 84:12375–12384 [View Article][PubMed]
    [Google Scholar]
  20. Hall T. A. 1999; BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT.. Nucleic Acids Symp Ser 41:95–98
    [Google Scholar]
  21. Hunter P. 1998; Vaccination as a means of control of foot-and-mouth disease in sub-saharan Africa. Vaccine 16:261–264 [View Article][PubMed]
    [Google Scholar]
  22. Jangra R. K., Tosh C., Sanyal A., Hemadri D., Bandyopadhyay S. K. 2005; Antigenic and genetic analyses of foot-and-mouth disease virus type A isolates for selection of candidate vaccine strain reveals emergence of a variant virus that is responsible for most recent outbreaks in India. Virus Res 112:52–59 [View Article][PubMed]
    [Google Scholar]
  23. Kitson J. D. A., McCahon D., Belsham G. J. 1990; Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179:26–34 [View Article][PubMed]
    [Google Scholar]
  24. Knowles N. J., Samuel A. R. 2003; Molecular epidemiology of foot-and-mouth disease virus. Virus Res 91:65–80 [View Article][PubMed]
    [Google Scholar]
  25. Lea S., Abu-Ghazaleh R., Blakemore W., Curry S., Fry E., Jackson T., King A., Logan D., Newman J., Stuart D. 1995; Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67. Structure 3:571–580 [View Article][PubMed]
    [Google Scholar]
  26. Logan D., Abu-Ghazaleh R., Blakemore W., Curry S., Jackson T., King A., Lea S., Lewis R., Newman J. et al. other authors 1993; Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362:566–568 [View Article][PubMed]
    [Google Scholar]
  27. Mateu M. G. 1995; Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res 38:1–24 [View Article][PubMed]
    [Google Scholar]
  28. Mateu M. G., Andreu D., Domingo E. 1995; Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus. Virology 210:120–127 [View Article][PubMed]
    [Google Scholar]
  29. McCahon D., Crowther J. R., Belsham G. J., Kitson J. D. A., Duchesne M., Have P., Meloen R. H., Morgan D. O., De Simone F. 1989; Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants. J Gen Virol 70:639–645 [View Article][PubMed]
    [Google Scholar]
  30. Ndiritu C. G., Ouldridge E. J., Head M., Rweyemamu M. M. 1983; A serological evaluation of 1979–1982 Kenyan foot-and-mouth disease type SAT 2 viruses. J Hyg (Lond) 91:335–341 [View Article][PubMed]
    [Google Scholar]
  31. OIE 2009 In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals pp. 1–25 Paris: OIE;
    [Google Scholar]
  32. Paton D. J., Valarcher J.-F., Bergmann I., Matlho O. G., Zakharov V. M., Palma E. L., Thomson G. R. 2005; Selection of foot and mouth disease vaccine strains–a review. Rev Sci Tech 24:981–993[PubMed]
    [Google Scholar]
  33. Pérez Filgueira M., Wigdorovitz A., Romera A., Zamorano P., Borca M. V., Sadir A. M. 2000; Detection and characterization of functional T-cell epitopes on the structural proteins VP2, VP3, and VP4 of foot and mouth disease virus O1 campos. Virology 271:234–239 [View Article][PubMed]
    [Google Scholar]
  34. Reeve R., Blignaut B., Esterhuysen J. J., Opperman P., Matthews L., Fry E. E., de Beer T. A., Theron J., Rieder E. et al. other authors 2010; Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus. PLOS Comput Biol 6:e1001027 [View Article][PubMed]
    [Google Scholar]
  35. Rweyemamu M. M., Booth J. C., Head M., Pay T. W. F. 1978; Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains. J Hyg (Lond) 81:107–123 [View Article][PubMed]
    [Google Scholar]
  36. Rweyemamu M. M., Ouldridge E. J., Head M., Ferrari R. 1984; The effect of antiserum quality on strain specificity assessment of foot and mouth disease virus by the neutralization reaction. J Biol Stand 12:295–303 [View Article][PubMed]
    [Google Scholar]
  37. Sahle M., Dwarka R. M., Venter E. H., Vosloo W. 2007a; Comparison of SAT-1 foot-and-mouth disease virus isolates obtained from East Africa between 1971 and 2000 with viruses from the rest of sub-Saharan Africa. Arch Virol 152:797–804 [View Article][PubMed]
    [Google Scholar]
  38. Sahle M., Dwarka R. M., Venter E. H., Vosloo W. 2007b; Study of the genetic heterogeneity of SAT-2 foot-and-mouth disease virus in sub-Saharan Africa with specific focus on East Africa. Onderstepoort J Vet Res 74:289–299[PubMed] [CrossRef]
    [Google Scholar]
  39. Saiz J. C., Gonzalez M. J., Borca M. V., Sobrino F., Moore D. M. 1991; Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol 65:2518–2524[PubMed]
    [Google Scholar]
  40. Sali A., Blundell T. L. 1993; Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779–815 [CrossRef]
    [Google Scholar]
  41. Samuel A. R., Knowles N. J. 2001; Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J Gen Virol 82:609–621[PubMed]
    [Google Scholar]
  42. Samuel A. R., Ouldridge E. J., Arrowsmith A. E. M., Kitching R. P., Knowles N. J. 1990; Antigenic analysis of serotype O foot-and-mouth disease virus isolates from the Middle East, 1981 to 1988. Vaccine 8:390–396 [View Article][PubMed]
    [Google Scholar]
  43. Sangare O., Bastos A. D. S., Venter E. H., Vosloo W. 2003; Retrospective genetic analysis of SAT-1 type foot-and-mouth disease outbreaks in West Africa (1975–1981). Vet Microbiol 93:279–289 [View Article][PubMed]
    [Google Scholar]
  44. Sangaré O., Bastos A. D. S., Venter E. H., Vosloo W. 2004; A first molecular epidemiological study of SAT-2 type foot-and-mouth disease viruses in West Africa. Epidemiol Infect 132:525–532 [View Article][PubMed]
    [Google Scholar]
  45. Schneider T. D., Stephens R. M. 1990; Sequence logos: a new way to display consensus sequences. Nucleic Acids Res 18:6097–6100 [View Article][PubMed]
    [Google Scholar]
  46. Tamura K., Dudley J., Nei M., Kumar S. 2007; mega4: Molecular Evolutionary Genetics Analysis (mega) software version 4.0. Mol Biol Evol 24:1596–1599 [View Article][PubMed]
    [Google Scholar]
  47. Thomas A. A. M., Woortmeijer R. J., Puijk W., Barteling S. J. 1988; Antigenic sites on foot-and-mouth disease virus type A10. J Virol 62:2782–2789[PubMed]
    [Google Scholar]
  48. Thompson J. D., Gibson T. J., Plewniak F., Jeanmougin F., Higgins D. G. 1997; The clustal_x windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876–4882 [View Article][PubMed]
    [Google Scholar]
  49. Thomson G. R. 1994; Foot-and-mouth disease. In Infectious Diseases of Livestock with Special Reference to Southern Africa pp. 825–952 Edited by Coetzer J. A. W., Thomson G. R., Tustin R. C. Cape Town, London, New York: Oxford University Press;
    [Google Scholar]
  50. Usherwood E. J., Nash A. A. 1995; Lymphocyte recognition of picornaviruses. J Gen Virol 76:499–508 [View Article][PubMed]
    [Google Scholar]
  51. van Rensburg H. G., Nel L. H. 1999; Characterization of the structural-protein-coding region of SAT 2 type foot-and-mouth disease virus. Virus Genes 19:229–233 [View Article][PubMed]
    [Google Scholar]
  52. van Rensburg H., Haydon D., Joubert F., Bastos A., Heath L., Nel L. H. 2002; Genetic heterogeneity in the foot-and-mouth disease virus Leader and 3C proteinases. Gene 289:19–29 [View Article][PubMed]
    [Google Scholar]
  53. Vosloo W., Thomson G. R. 2004; Foot-and-mouth disease. In Natural Habitats in which Foot-and-Mouth Disease Viruses are Maintained pp. 383–410 Edited by Domingo E., Sobrino F. Horizon Scientific Press;
    [Google Scholar]
  54. Vosloo W., Knowles N. J., Thomson G. R. 1992; Genetic relationships between southern African SAT-2 isolates of foot-and-mouth-disease virus. Epidemiol Infect 109:547–558 [View Article][PubMed]
    [Google Scholar]
  55. Vosloo W., Kirkbride E., Bengis R. G., Keet D. F., Thomson G. R. 1995; Genome variation in the SAT types of foot-and-mouth disease viruses prevalent in buffalo (Syncerus caffer) in the Kruger National Park and other regions of southern Africa, 1986–93. Epidemiol Infect 114:203–218 [View Article][PubMed]
    [Google Scholar]
  56. Vosloo W., Bastos A. D., Kirkbride E., Esterhuysen J. J., van Rensburg D. J., Bengis R. G., Keet D. W., Thomson G. R. 1996; Persistent infection of African buffalo (Syncerus caffer) with SAT-type foot-and-mouth disease viruses: rate of fixation of mutations, antigenic change and interspecies transmission. J Gen Virol 77:1457–1467 [View Article][PubMed]
    [Google Scholar]
  57. Vosloo W., Bastos A. D. S., Sangare O., Hargreaves S. K., Thomson G. R. 2002; Review of the status and control of foot and mouth disease in sub-Saharan Africa. Rev Sci Tech 21:437–449[PubMed]
    [Google Scholar]
  58. Vosloo W., Bastos A. D., Boshoff C. I. 2006; Retrospective genetic analysis of SAT-1 type foot-and-mouth disease outbreaks in southern Africa. Arch Virol 151:285–298 [View Article][PubMed]
    [Google Scholar]
  59. Xie Q. C., McCahon D., Crowther J. R., Belsham G. J., McCullough K. C. 1987; Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol 68:1637–1647 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.032839-0
Loading
/content/journal/jgv/10.1099/vir.0.032839-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error